Biotechnology Stocks I Performance Guide: Tarsus Pharmaceuticals, Inc. (TARS)
TARS has no dividends.
Table and Chart of TARS Performance
See what a $1,000 investment in TARS is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| TARS Returns | |
|---|---|
| Start Date | Nov-30-2020 |
| Start Price | $24.17 |
| End Date | Oct-11-2024 |
| End Price | $35.71 |
| # Prices | 48 |
| Min Date | Mar-31-2023 |
| Min Price | $12.57 |
| Max Date | Dec-31-2020 |
| Max Price | $41.33 |
| Total Return | 47.75% |
| Annualized Return | 10.25% |
| Current Value of $1,000 Purchase | $1,477 |
| Number Returns | 1,128 |
| Average Return | 8.26% |
| Number Profitable Returns | 510 |
| Percent Profitable Returns | 45.21% |
| Number Unprofitable Returns | 618 |
| Percent Unprofitable Returns | 54.79% |
| Profitable to Unprofitable Returns Ratio | 0.83 |
| TARS Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,024 |
| Beta | -3.232 | Price to Sales |
| Earnings per Share | $0.0000 |
| PE Ratio | -155271008 |
| PE to Growth Ratio | None |
| Price to Book | 16.29 |
| PRICE DATA | |
| 52 Week High | $1.078 |
| 52 Week Low | $42.5 |
| Analyst Target Price | $10.05 |
| 50-Day Moving Average | $12.57 |
| 200-Day Moving Average | $29.52 |
| FINANCIAL DATA | |
| Revenue per Share | $-4.46 |
| Revenue | $-1 |
| Profit Margin | 243.4% |
| Return on Equity | -34.5% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
TARS Compare Returns with S&P 500
TARS Trendline Chart
TARS Moving Average Chart
TARS Stock Return Map - See Patterns of Gains and Losses
TARS Stock Returns/Purchase Dates